VEROTREXED®

PEMETREXED
VEROTREXED®

Available Presentations:

  • LYOPHILIZATE FOR SOLUTION FOR INFUSION, 100 mg and 500 mg
INN: pemetrexed
Presentation:
Lyophilizate for solution for infusion, 100 mg and 500 mg.
ATC Group: L01BA04
Antitumoral, antimetabolite.
Scope of Application:
• Locally advanced or metastatic non-squamous non-small-cell lung cancer
• Malignant pleural mesothelioma
Status of Administration: prescription only
VED Status: listed in VED List
Marketing Authorization: ЛП-004688
Shelf Life: lyophilizate: 2 years
Conditions of Storage: store at or below 25°C

THE INFORMATION ON THIS PAGE IS NOT AN ADVERTISEMENT AND IS INTENDED TO INFORM ON THE PRODUCTS MANUFACTURED BY THE COMPANY.

THE MEDICINAL PRODUCTS HAVE CONTRAINDICATIONS, CONTACT YOUR DOCTOR.